En breve, dos vacunas podrían proteger a los adultos mayores del VSR
JUEVES, 16 de febrero de 2023 (HealthDay News) — Las personas mayores cuentan con vacunas para prevenir una influenza y una COVID-19 graves, pero no ha habido nada que las proteja contra el tercer virus respiratorio que contribuyó a la terrible “trip…
Learn MoreIrregular Heartbeat: What Is It and How Do You Treat It?
MONDAY, Feb. 20, 2023 (HealthDay News) — Many things can make your heart skip a beat — the words to a song, a case of the nerves or a near car accident — but these temporary palpitations aren’t usually cause for concern. But much more serious, and so…
Learn MoreRucaparib Efficacious in Metastatic Castration-Resistant Prostate Cancer
FRIDAY, Feb. 17, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival compared with a control m…
Learn MoreRisk for Prediabetes, Diabetes Increased for Those Delivering Large Infants
FRIDAY, Feb. 17, 2023 (HealthDay News) — Having a large-for-gestational-age (LGA) infant is associated with an increased risk for being diagnosed with prediabetes or diabetes 10 to 14 years postpartum, according to a study presented at The Pregnancy …
Learn MoreIntrauterine Vacuum-Induced Hemorrhage Control Device Safe
FRIDAY, Feb. 17, 2023 (HealthDay News) — The Jada System, an intrauterine vacuum-induced hemorrhage control device, is safe and effective in a real-world setting, according to a study presented at The Pregnancy Meeting, the annual meeting of the Soci…
Learn MoreDeep Learning Model Helps Predict Neonatal Outcomes
FRIDAY, Feb. 17, 2023 (HealthDay News) — A multitask deep learning model based on data from electronic health records (EHRs) can predict neonatal outcomes, according to a study published in the Feb. 15 issue of Science Translational Medicine.Davide D…
Learn MoreTalazoparib + Enzalutamide Beneficial in Metastatic Prostate Cancer
FRIDAY, Feb. 17, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according to a study presented at t…
Learn MoreGood Heart Health in Midlife May Protect Against Depressive Symptoms
FRIDAY, Feb. 17, 2023 (HealthDay News) — Better cardiovascular health in midlife is associated with a lower risk for depressive symptoms over time, according to a study published online Feb. 15 in JAMA Psychiatry.Thomas T. van Sloten, M.D., from Univ…
Learn MoreLong COVID Tied to Lower Likelihood of Employment
FRIDAY, Feb. 17, 2023 (HealthDay News) — Post-COVID-19 condition (PCC) is associated with a greater likelihood of unemployment and lower likelihood of working full time, according to a study published online Feb. 15 in JAMA Network Open.Roy H. Perlis…
Learn MoreChildren’s Screen Time Use Remains Higher Than Prepandemic
FRIDAY, Feb. 17, 2023 (HealthDay News) — Screen time among children increased during the COVID-19 pandemic and remained elevated after public health precautions were lifted, according to a study published online Feb. 15 in JAMA Network Open.Monique M…
Learn More